Bradley Scroggins

Program Director

Translational Research Program

Portfolios: Bladder, Prostate, and Radiosensitization

Bradley Scroggins, PhD, has served as a Program Director in the Translational Research Program within the Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI) since 2023. Prior to joining, Dr. Scroggins worked in the NCI intramural Radiation Oncology Branch and the Urologic Oncology Branch. Dr. Scroggins has expertise in preclinical models of prostate, bladder, kidney cancer, radiation oncology and normal tissue damage, and protein homeostasis.